title: Cyberknife radiotherapy and anastrozole for the treatment of advanced progressive low-grade papillary serous ovarian carcinoma: A case report.
abstract: •Low-grade papillary serous ovarian carcinoma has unique epidemiologic and disease-specific characteristics•Cyberknife radiotherapy is a unique treatment that may successfully be used to treat unresectable disease•Anastrozole is an effective treatment for hormone receptor-positive low-grade papillary serous ovarian carcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, University Hospitals Case Medical Center, Cleveland, OH, USA.
authors.forename: Shandhini
authors.initials: S
authors.lastname: Raidoo
authors.affiliation: Department of Obstetrics and Gynecology, University Hospitals Case Medical Center, Cleveland, OH, USA.
authors.forename: Sareena
authors.initials: S
authors.lastname: Singh
authors.affiliation: Department of Pathology, University Hospitals Case Medical Center, Cleveland, OH, USA.
authors.forename: Raymond
authors.initials: R
authors.lastname: Redline
authors.affiliation: Department of Obstetrics and Gynecology, Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Debernardo
keywords: Anastrozole; Cyberknife; Low-grade; Ovarian